Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 3279

AbbVie finally enters obesity race with $350M upfront for Gubra’s amylin

$
0
0
One of the last big pharma holdouts in obesity has now entered what has become the most sought-after field in the industry. AbbVie said Monday morning it's making the leap into the obesity field for ...

Viewing all articles
Browse latest Browse all 3279

Trending Articles